China Pharma Holdings, Inc.

Second Floor, No. 17, Jinpan Road

Haikou, Hainan Province, China 570216

December 29, 2011

VIA EDGAR

Ms. Tabatha Akins

Staff Accountant

Division of Corporation Finance

Securities and Exchange Commission

100 F Street, NE

Washington, D.C. 20549

Re:	China Pharma Holdings, Inc.
	Form 10-K for the fiscal year ended December 31, 2010
	Filed March 3, 2011 and Amended March 17, 2011
	Form 10-Q for the period ended March 31, 2011
	Filed May 10, 2011
	File No. 001-34471

Dear Ms. Akins:

China Pharma Holdings, Inc., a Delaware corporation (the “Company”), is in receipt of the letter from the staff of the Securities and Exchange Commission dated December 16, 2011 (the “Comment Letter”) to the Company, with respect to the subject filings.

As part of the discussion on the conference call among you, our auditor, Douglas D. Hawkes, Partner of HANSEN, BARNETT & MAXWELL, P.C. and our legal counsel, Elizabeth Chen, Partner of Pryor Cashman LLP on December 28, 2011, due to the holiday season and the efforts the Company needs to gather for a thorough response to the Comment Letter,  we hereby submit this written extension request for an extension of ten business days from the initial response due date January 3, 2012.  We expect to respond to the Comment Letter by January 18, 2012.

Please feel free to contact me or Elizabeth Chen, Esq. at 212-326-0199 or via fax at 212-798-6366,  in case you have any further comments or questions in this regard.

Very truly yours,

/s/ Zhilin Li

Zhilin Li

Chief Executive Officer